Retour
Fourchette du Jour
67,00 €
71,57 €
Fourchette 52 Semaines
66,50 €
112,30 €
Volume
200
Moyenne 50J / 200J
82,13 €
/
89,63 €
Clôture Précédente
67,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 19,2 | 0,3 |
| P/B | 2,0 | 2,9 |
| ROE % | 11,3 | 3,7 |
| Net Margin % | 15,9 | 3,8 |
| Rev Growth 5Y % | 7,7 | 10,0 |
| D/E | 0,6 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
7,02 €
6,76 € – 7,32 €
|
1,5 B | 1 |
| FY2028 |
5,95 €
5,73 € – 6,20 €
|
1,4 B | 1 |
| FY2027 |
5,33 €
5,13 € – 5,55 €
|
1,3 B | 1 |
Points Clés
Revenue grew 7,69% annually over 5 years — modest growth
Earnings grew 17,68% over the past year
ROE of 11,27% — decent returns on equity
Net margin of 15,87% shows strong profitability
Generating 239,07M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,45%
Croissance
Revenue Growth (5Y)
7,69%
Revenue (1Y)3,24%
Earnings (1Y)17,68%
FCF Growth (3Y)-6,87%
Qualité
Return on Equity
11,27%
ROIC6,88%
Net Margin15,87%
Op. Margin21,79%
Sécurité
Debt / Equity
0,56
Current Ratio3,39
Interest Coverage9,03
Valorisation
P/E Ratio
19,21
P/B Ratio2,01
EV/EBITDA16,58
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,24% | Revenue Growth (3Y) | -6,68% |
| Earnings Growth (1Y) | 17,68% | Earnings Growth (3Y) | -11,64% |
| Revenue Growth (5Y) | 7,69% | Earnings Growth (5Y) | -6,67% |
| Profitability | |||
| Revenue (TTM) | 1,19B | Net Income (TTM) | 188,11M |
| ROE | 11,27% | ROA | 5,69% |
| Gross Margin | 65,94% | Operating Margin | 21,79% |
| Net Margin | 15,87% | Free Cash Flow (TTM) | 239,07M |
| ROIC | 6,88% | FCF Growth (3Y) | -6,87% |
| Safety | |||
| Debt / Equity | 0,56 | Current Ratio | 3,39 |
| Interest Coverage | 9,03 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 19,21 | P/B Ratio | 2,01 |
| P/S Ratio | 3,05 | PEG Ratio | 1,76 |
| EV/EBITDA | 16,58 | Dividend Yield | 0,01% |
| Market Cap | 3,61B | Enterprise Value | 4,28B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,19B | 1,15B | 1,36B | 1,24B | 881,31M |
| Net Income | 188,11M | 159,85M | 240,91M | 310,97M | 247,87M |
| EPS (Diluted) | 3,37 | 2,87 | 4,15 | 5,40 | 4,50 |
| Gross Profit | 781,70M | 741,19M | 900,61M | 824,77M | 602,91M |
| Operating Income | 258,33M | 216,26M | 351,26M | 419,50M | 324,23M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3,30B | 3,21B | 3,41B | 3,23B | 1,25B |
| Total Liabilities | 1,51B | 1,67B | 1,89B | 1,86B | 290,13M |
| Shareholders' Equity | 1,80B | 1,54B | 1,52B | 1,37B | 954,68M |
| Total Debt | 1,01B | 1,19B | 1,35B | 1,40B | 34,66M |
| Cash & Equivalents | 344,27M | 280,31M | 241,78M | 403,02M | 339,88M |
| Current Assets | 932,53M | 982,69M | 1,07B | 958,29M | 713,92M |
| Current Liabilities | 275,30M | 320,12M | 347,02M | 298,23M | 160,21M |